Physician profile
Jeff J Dyer
NPI 1649215260
$330.02
in general payments reported to CMS, 2019-2025
14 companies · $32.10 in 2025
The $32.10 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $202 · 2023: $38.79 · 2024: $57.05 · 2025: $32.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $127.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $52.47 | 2019-2025 | |
| Novo Nordisk INC | $37.48 | 2019-2023 | Wegovy |
| Amgen INC. | $36.13 | 2019-2025 | Repatha, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.70 | 2023 | Jardiance |
| Abbott Laboratories | $22.57 | 2024 | Freestyle Libre 3 |
| Amag Pharmaceuticals, INC. | $21.81 | 2019 | |
| Astellas Pharma US INC | $18.90 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $17.99 | 2019 | |
| Therapeuticsmd, INC. | $17.89 | 2019 | |
| Merck Sharp & Dohme LLC | $17.54 | 2019 | |
| Boston Scientific Corporation | $17.49 | 2024 | Watchman Flx |
| Amarin Pharma, INC. | $15.64 | 2019 | |
| Sanofi-Aventis U.S. LLC | $15.47 | 2019 | |
| Pfizer INC. | $13.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeff Dyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.